Toll-like receptor 4 signalling attenuates experimental allergic conjunctivitis.

Area of Science:

• Immunology
• Ophthalmology

Background:

• Allergic conjunctivitis involves T helper type 2 (Th2) responses and eosinophil infiltration.
• Toll-like receptor 4 (TLR-4) signaling is linked to adaptive immunity in allergic airway disease.

Purpose of the Study:

• To investigate the effect of bacterial lipopolysaccharide (LPS) on allergic conjunctivitis development.
• To determine if LPS modulates immune responses to ovalbumin (OVA) allergen in an experimental allergic conjunctivitis (EAC) model via TLR-4.

Main Methods:

• Mice were sensitized with OVA and challenged to induce allergic conjunctivitis.
• LPS was administered with OVA during sensitization in wild-type and TLR-4(-/-) mice.
• Allergic indicators, including immunoglobulin E (IgE) and cytokine levels, were evaluated.

Main Results:

• LPS administration significantly suppressed IgE-mediated and eosinophil-dependent conjunctival inflammation.
• Mice treated with OVA plus LPS showed reduced levels of interleukin-4 (IL-4), IL-5, and eotaxin.
• LPS-induced suppression of allergic responses was dependent on TLR-4 signaling and associated with a Th1 shift.

Conclusions:

• LPS suppresses Th2-driven allergic conjunctivitis through a TLR-4-dependent mechanism.
• This study demonstrates the potential of LPS in modulating allergic inflammation via TLR-4 in an EAC model.